A 0.5-tonne superconducting magnet recently hovered silently inside a 5-meter-wide vacuum chamber, which marked ...
Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an inadequate ...